How can I differentiate opioid overdose from stimulant overdose and what are the emergency management steps for each?

Differentiating Opioid from Stimulant Overdose and Emergency Management

Opioid overdose presents with CNS/respiratory depression, pinpoint pupils, and bradycardia, while stimulant overdose presents with agitation, tachycardia, hypertension, hyperthermia, and seizures—but in cardiac arrest, immediately initiate high-quality CPR with compressions plus ventilation regardless of suspected drug type, as this takes absolute priority over any antidote administration. 1, 2

Clinical Differentiation

Opioid Overdose Toxidrome 3

• CNS/Respiratory depression: Unresponsiveness, decreased level of consciousness
• Respiratory findings: Slow, shallow breathing progressing to respiratory arrest; gasping or apnea
• Cardiovascular: Bradycardia, hypotension (in severe cases)
• Pupils: Miosis (pinpoint pupils) - strongly correlated with opioid toxicity
• Skin: Cool, clammy
• Progression: Respiratory arrest → cardiac arrest

Stimulant Overdose Toxidrome ("Overamping") 3, 4

• CNS findings: Agitation, anxiety, confusion, seizures, audiovisual hallucinations
• Cardiovascular: Tachycardia, hypertension, cardiac arrhythmias, potential cardiac arrest
• Hyperthermia: Elevated body temperature
• Pupils: Mydriasis (dilated pupils)
• Other: Diaphoresis, tremors, incontinence (in severe cases)
• Presentation variability: No unified understanding exists; substantial variation in severity and presentation 4

Critical Caveat: Polysubstance Use

Most overdose deaths involve co-ingestion of multiple drugs 1, 5. Approximately 50-54% of opioid overdoses also involve stimulants 6, 7, making pure toxidromes less common in real-world practice. Fentanyl was detected in 35% of suspected stimulant-only presentations 7.

---

Emergency Management Algorithm

Step 1: Initial Assessment (All Overdoses)

1. Scene safety first
2. Check responsiveness and breathing
3. Activate emergency response system immediately - do NOT delay for naloxone response 1, 8, 9
4. Assess for pulse (trained providers only; unreliable in lay rescuer settings)

Step 2: Management Based on Clinical Status

If CARDIAC ARREST (no pulse or lay rescuer finds unresponsive + not breathing normally):

Immediate Actions 1, 2:

1. Begin high-quality CPR immediately (compressions + ventilation at 30:2 ratio for single rescuer, 15:2 for two rescuers)
   • Press hard, press fast (100-120/min)
   • Compress at least 2 inches deep
   • Allow full chest recoil
2. Apply AED as soon as available and follow prompts
3. Continue standard BLS/ACLS protocols

Naloxone in Cardiac Arrest:

• Naloxone has NO proven benefit in cardiac arrest 1, 3, 9
• May administer naloxone IF it does not delay CPR, but CPR is the priority 1, 2
• Naloxone does not reverse ventricular fibrillation 2
• Standard resuscitation takes absolute priority 2

Stimulant-Related Cardiac Arrest:

• No specific antidote exists
• Follow standard ACLS algorithms 3
• Address arrhythmias per ACLS protocols
• Manage hyperthermia if present

---

If RESPIRATORY ARREST (has pulse but not breathing normally/only gasping):

Opioid-Suspected Respiratory Arrest 1, 8, 1, 9:

1. Open airway
2. Provide rescue breathing/bag-mask ventilation - this is the highest priority 1
3. Administer naloxone (reasonable to give in addition to ventilation) 1, 9:
   • Intranasal: 2-4 mg (most common pre-hospital route) 5
   • IV/IM: Start with 0.04-0.4 mg to minimize withdrawal 3
   • Repeat every 2-3 minutes if no response
   • May escalate to 2 mg or higher for synthetic opioids 3
   • Alternative: Nalmefene (prescription only) 2
4. Continue ventilation until spontaneous breathing returns 1
5. Place advanced airway if no response to naloxone 3

Stimulant-Related Respiratory Depression:

• Primarily supportive care with ventilation
• No specific antidote
• Naloxone will NOT help 2
• Address seizures with benzodiazepines if present
• Manage hyperthermia with cooling measures

---

Step 3: Post-Resuscitation Care

After Naloxone Response 9:

• Observe for re-sedation - naloxone duration is 45-70 minutes 3
• Short-acting opioids (heroin, morphine): Brief observation may suffice
• Long-acting opioids (methadone, sustained-release formulations): Prolonged observation required 3, 9
• Hospital observation mandatory after return of spontaneous breathing 9

Naloxone-Induced Withdrawal 3, 5:

• Expect: Agitation, hypertension, tachycardia, vomiting, piloerection
• Rarely life-threatening
• Minimize by using lowest effective dose

---

Key Clinical Pitfalls

1. Do not withhold CPR to give naloxone in cardiac arrest - CPR saves lives, naloxone does not in arrest 1, 2

2. Do not assume pure opioid toxicity - 50%+ involve stimulants or other drugs 6, 7

3. Stimulant co-involvement increases naloxone requirements (mean 2.79 mg vs 2.12 mg) and mortality 6, 10

4. Pulse checks are unreliable - when in doubt, start CPR 5

5. Naloxone takes several minutes to work, especially intranasal/IM routes - continue ventilation 2

6. Nonopioid sedatives (benzodiazepines) commonly contribute to respiratory depression and are NOT reversed by naloxone 2

7. Re-sedation is common - never discharge without adequate observation 3, 9

---

Summary Management Priorities

For ANY suspected overdose with cardiac arrest: High-quality CPR (compressions + ventilation) is the definitive intervention 1, 2

For opioid respiratory arrest: Ventilation FIRST, then naloxone as adjunct 1, 9

For stimulant toxicity: Supportive care, manage complications (seizures, hyperthermia, arrhythmias), no specific antidote 3

Always activate emergency services immediately - do not wait for drug response 1, 8, 9